[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.65.227. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
March 1, 2000

Safety of Antidepressant Medications During Pregnancy—Reply

Author Affiliations
 

Phil B.FontanarosaMD, Deputy EditorIndividualAuthorStephen J.LurieMD, PhD, Fishbein FellowIndividualAuthor

JAMA. 2000;283(9):1139. doi:10.1001/jama.283.9.1137

In Reply: We included prospective studies in which outcomes for antidepressant-exposed mothers and infants were compared with outcomes for nonteratogen-exposed mothers and infants. Information from pregnancy registries and other studies without control groups has limited usefulness due to methodological weaknesses, as demonstrated in the lithium registry.1 Our goal was to provide a critical review of select articles and a framework for conceptualization of information in the risk-benefit decision-making process. General reviews of antidepressant use during pregnancy have been published elsewhere.2,3

First Page Preview View Large
First page PDF preview
First page PDF preview
×